Our helpline: 01924 200799 Mon-Fri, 9am-4pm

The TABLET trial: results

5th April 2019

The results of the TABLET trial have just been published in the online edition of the New England Journal of Medicine.

Sadly, they show that the use of Levothyroxine did not reduce the risk of miscarriage in women who have thyroid antibodies but who are ‘euthyroid’ – that is, their thyroid hormones are in the normal range (described as euthyroid).

The results also showed that Levothyroxine also did not result in a higher rate of live births beyond 34 weeks.

You can read more about the trial here.

Latest news

New clinical guidance and patient information from the RCOG

3rd April 2020

The Royal College of Obstetricians and Gynaecologists have this evening published guidance for rationalising early pregnancy services during the coronavirus (COVID-19) pandemic.  The guidance has been produced to support early pregnancy services during the evolving COVID-19 pandemic, with two audiences in mind: Clinicians and service and hospital managers Pages 2-11 are primarily for clinicians and […]

Continue reading »